Literature DB >> 34993705

Protective Effect of Mild Hypothermia on Spinal Cord Ischemia-Induced Delayed Paralysis and Spinal Cord Injury.

Dan Fu1, Cai Chen2, Liang He3, Jingjuan Li4, Aiguo Li2.   

Abstract

To explore the mechanism regarding the regulation of spinal cord ischemia (SCI) in rats by mild hypothermia. A SCI rat model was established through aorta occlusion, and in some cases, the rats were intervened with mild hypothermia, after which motor function, microglia activation, and M1/M2 polarization in rats were measured. Also, the expression of inflammatory cytokines (IL-1β, IL-6 and TNF-α) and neuronal apoptosis were examined. Lipopolysaccharide (LPS)-induced M1 microglia and IL-4-induced M2 microglia were intrathecally injected into rats to evaluate the effect of microglial polarization on SCI. In in vitro experiments, primary microglial cells were treated under hypothermic condition, in which M1/M2 polarization and microglia apoptosis, the levels of iNOS, CD86, CD206, Arg-1 and inflammatory cytokines were assessed. Western blot analysis detected the activation of the TLR4/NF-κB pathway to investigate the role of this pathway in M1/M2 polarization. SCI treatment impaired motor function, induced higher M1 microglia proportion, and increased the levels of pro-inflammatory cytokines in rats, and mild hypothermic treatment attenuated these trends. Moreover, injection of M1 microglia increased M1 microglia proportion and increased the levels of pro-inflammatory cytokines, while injection of M2 microglia induced the reverse results, i.e. decreased M1 microglia proportion and reduced pro-inflammatory cytokine levels. In LPS-induced microglial cells, mild hypothermia treatment increased M2 microglia proportion and decreased pro-inflammatory cytokine levels, relative to normothermia. Mild hypothermia inactivated the TLR4/NF-κB pathway in LPS-treated microglia. TLR4 overexpression reversed the function of mild hypothermia in LPS-stimulated microglia, and under normal condition, TLR4/NF-κB pathway suppressed microglial M2 polarization. Mild hypothermia inhibits TLR4/NF-κB pathway and promotes microglial M2 polarization, thus attenuating SCI-induced injury and inflammation.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Basso, Beattie, and Bresnahan rating scale; Delayed paralysis; Microglia polarization; Mild hypothermia; Spinal cord injury; Spinal cord ischemia

Mesh:

Year:  2022        PMID: 34993705     DOI: 10.1007/s11064-021-03515-7

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  35 in total

1.  Moderate hypothermia increased the incidence of delayed paralysis through activation of the spinal microglia in an aortic cross-clamping rat model.

Authors:  Liang He; Jun-Mei Xu; Hui Li; Feng Zhong; Zhi Liu; Chang-Qi Li; Ru-Ping Dai
Journal:  Int J Cardiol       Date:  2016-06-27       Impact factor: 4.164

Review 2.  Current and emerging treatment options for spinal cord ischemia.

Authors:  Raffaele Nardone; Slaven Pikija; J Sebastian Mutzenbach; Martin Seidl; Stefan Leis; Eugen Trinka; Johann Sellner
Journal:  Drug Discov Today       Date:  2016-06-17       Impact factor: 7.851

3.  Deficiency in the voltage-gated proton channel Hv1 increases M2 polarization of microglia and attenuates brain damage from photothrombotic ischemic stroke.

Authors:  Dai-Shi Tian; Chun-Yu Li; Chuan Qin; Madhuvika Murugan; Long-Jun Wu; Jun-Li Liu
Journal:  J Neurochem       Date:  2016-09-09       Impact factor: 5.372

4.  Exosomes from LPS-stimulated macrophages induce neuroprotection and functional improvement after ischemic stroke by modulating microglial polarization.

Authors:  Yan Zheng; Ruyi He; Peng Wang; Yijie Shi; Liang Zhao; Jia Liang
Journal:  Biomater Sci       Date:  2019-04-23       Impact factor: 6.843

5.  A peroxisome proliferator-activated receptor gamma agonist attenuates neurological deficits following spinal cord ischemia in rats.

Authors:  Hyunchang Kim; Jinyoung Hwang; Sanghon Park; Sahngun Francis Nahm; Sungwon Min; Cheong Lim; Kayhyun Park; Sunghee Han
Journal:  J Vasc Surg       Date:  2013-07-02       Impact factor: 4.268

6.  Intrathecal granulocyte colony-stimulating factor modulate glial cell line-derived neurotrophic factor and vascular endothelial growth factor A expression in glial cells after experimental spinal cord ischemia.

Authors:  C-H Chen; S-Y Huang; N-F Chen; C-W Feng; H-C Hung; C-S Sung; Y-H Jean; Z-H Wen; W-F Chen
Journal:  Neuroscience       Date:  2013-03-30       Impact factor: 3.590

7.  Ethyl pyruvate modulates delayed paralysis following thoracic aortic ischemia reperfusion in mice.

Authors:  Bao-Ngoc Nguyen; Hassan Albadawi; Rahmi Oklu; Robert S Crawford; Mitchell P Fink; Richard P Cambria; Michael T Watkins
Journal:  J Vasc Surg       Date:  2016-11       Impact factor: 4.268

8.  Cysteinyl Leukotriene Receptor 2 is Involved in Inflammation and Neuronal Damage by Mediating Microglia M1/M2 Polarization through NF-κB Pathway.

Authors:  Rui Zhao; Miaofa Ying; Shenglong Gu; Wei Yin; Yanwei Li; Hong Yuan; Sanhua Fang; Mingxing Li
Journal:  Neuroscience       Date:  2019-11-11       Impact factor: 3.590

9.  Interruption of spinal cord microglial signaling by alpha-2 agonist dexmedetomidine in a murine model of delayed paraplegia.

Authors:  Marshall T Bell; Viktor A Agoston; Kirsten A Freeman; Ferenc Puskas; Paco S Herson; Joshua Mares; David A Fullerton; T Brett Reece
Journal:  J Vasc Surg       Date:  2013-07-11       Impact factor: 4.268

10.  A mouse model of ischemic spinal cord injury with delayed paralysis caused by aortic cross-clamping.

Authors:  Hamdy Awad; Daniel P Ankeny; Zhen Guan; Ping Wei; Dana M McTigue; Phillip G Popovich
Journal:  Anesthesiology       Date:  2010-10       Impact factor: 7.892

View more
  1 in total

1.  TAZ Induces Migration of Microglia and Promotes Neurological Recovery After Spinal Cord Injury.

Authors:  Xuyang Hu; Jinxin Huang; Yiteng Li; Lei Dong; Yihao Chen; Fangru Ouyang; Jianjian Li; Ziyu Li; Juehua Jing; Li Cheng
Journal:  Front Pharmacol       Date:  2022-06-27       Impact factor: 5.988

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.